CD276 and acute myeloid leukemia: Furthermore, we searched DiseaseMeth Databases (http://bioinfo.hrbmu.edu.cn/diseasemeth) and consistently confirmed that the methylation or low methylation level of the B7-H3 promoter region had no marked difference between the AML group and controls (P = 0.6366).